FOXC1对上皮性卵巢癌SKOV3细胞生物学功能的影响及相关机制的初步研究
本文选题:上皮性卵巢癌 + 叉头框转录因子FOXC1 ; 参考:《郑州大学》2017年硕士论文
【摘要】:上皮性卵巢癌(Epithelial ovarian cancer,EOC)是女性最常见的生殖系统恶性肿瘤之一。目前,EOC在发达国家的病死率已居妇科肿瘤之首。对恶性肿瘤而言,肿瘤细胞除了呈现活跃的增殖状态外,受到威胁最严重的是肿瘤细胞所表现出来的侵袭迁移特性。目前,国内外对影响肿瘤细胞的生物学功能的部分基因已进行了相关靶点实验及探索,对其靶点进行干预的同时也促进了肿瘤治疗的发展,为靶向治疗提供了更多的参考。对于EOC而言,通过明确某些基因的异常表达是否能够引起上皮性卵巢癌细胞生物学行为的改变,进而探讨其调控机制,对EOC病因机制的深入研究及长远靶向治疗具有重要意义。转录因子FOXC1(forkhead box C1)是叉头框转录因子基因家族(FOX家族)的一员,是通过自身的叉头区DNA结合域结合目的基因片段从而启动相关基因转录。FOXC1除了参与细胞或器官分化及代谢等生物学过程外,目前证实FOXC1还可以调控多种肿瘤细胞信号传导途径,如NF-κB、Wnt/β-Catenin等。这些细胞信号通路与细胞增殖、侵袭、迁移、凋亡等密切相关,因此,FOXC1已成为肿瘤发病机制研究的热点。微小染色体维持蛋白2(minichromosomemai n-tenance proteins 2,MCM2)是细胞增殖活性判断的新指标,用来反映细胞增殖状态时能表现出更强的特异性及敏感性。基质金属蛋白酶9(matrix metallopro teinase,MMP9)作为细胞外基质降解的主要蛋白水解酶,与肿瘤细胞侵袭、转移相关的细胞外基质降解密切相关。因此当EOC中的肿瘤细胞发生增殖及侵袭等生物学行为时在分子水平常常能够检测到MCM2、MMP9的改变。近年来有报道称,在卵巢肿瘤组织中,FOXC1在良性上皮性卵巢肿瘤的表达率为84%,在上皮性卵巢癌中的表达率为37.5%。本课题组前期研究也发现,上皮性卵巢癌组织中的FOXC1 mRNA表达量较交界性卵巢上皮性肿瘤组织及良性卵巢上皮性肿瘤组织中减少,且FOXC1在组织中的mRNA表达量与淋巴结转移相关,提示FOXC1在组织中表达的缺失可能对上皮性卵巢癌的发生发展有重要意义。然而,FOXC1的异常表达能否引起上皮性卵巢癌细胞生物学功能的改变,如何参与EOC的发生发展尚不清楚。另外,大量研究显示,在EOC中NF-κB信号传导通路可以参与MCM2、MMP9的调控。因此,本课题将对FOXC1是否参与了上皮性卵巢癌细胞的恶性生物学行为,是否能通过NF-κB信号通路对其调控进行初步探讨。目的通过慢病毒感染方式在上皮性卵巢癌细胞SKOV3中构建FOXC1过表达及干扰稳定细胞株后,探讨FOXC1对SKOV3细胞增殖及侵袭能力的影响,并初步判断FOXC1是否可以通过激活NF-κB信号通路对其进行调控,分析EOC中FOXC1异常表达所扮演的角色。材料和方法1研究对象及分组本研究选用人上皮性卵巢癌细胞系SKOV3细胞(第四军医大学病原生物学教研室赵亚教授馈赠),应用RPMI-1640完全培养基,将细胞置于37℃、5%CO2的培养箱中进行培养。实验分组:实验组(FOXC1 Overexpress组、FOXC1shRNA组),载体对照组(Overexpress Control组、shRNA Control组)及空白对照组(Control组)。2实验方法在上皮性卵巢癌SKOV3细胞中分别感染慢病毒FOXC1 shRNA、FOXC1慢病毒载体过表达质粒,构建稳定细胞株后分别在mRNA和蛋白水平进行验证。应用CCK-8实验、Transwell实验,分别观察SKOV3细胞的增殖、侵袭能力的变化;通过qRT-PCR法检测比较各组MCM2、MMP9的mRNA水平的变化;采用Western blot法检测各组MCM2、MMP9、NF-κB p65、NF-κB p-p65的蛋白表达水平情况。3统计学处理采用SPSS21.0软件进行统计学分析。实验数据均以x±s表示,各组间数据的比较,正态分布的采用单因素方差分析和独立样本的t检验。偏态分布的计量资料各组间比较采用Kruskal-Wallis检验和秩和检验。检验水准α=0.05。结果1稳定株构建及鉴定情况经qRT-PCR筛选鉴定3条FOXC1干扰序列,FOXC1 shRNA1抑制效果最佳,选取该序列,通过感染及嘌呤霉素筛选后,应用Western blot验证,结果显示实验组FOXC1蛋白表达量较载体对照组及空白对照组明显减少,差异具有统计学意义(P0.05)。在SKOV3细胞中成功构建了FOXC1干扰稳定株。应用FOXC1慢病毒载体过表达质粒成功感染SKOV3细胞,经嘌呤霉素筛选,通过qRT-PCR和Western blot验证,实验组中FOXC1在mRNA的表达水平及蛋白水平均明显高于2组对照组,且差异有统计学意义(P0.05)。成功获得稳定过表达FOXC1的SKOV3细胞株。2 FOXC1对SKOV3细胞增殖、侵袭能力的影响情况2.1 FOXC1对各组SKOV3细胞增殖的影响情况通过CCK-8检测SKOV3细胞增殖能力结果显示:0h各组细胞吸光度值无差异。下调FOXC1组SKOV3细胞的增殖活性高于2组对照组,尤其48h后增殖活性明显增高,经统计学分析,差异均有统计学意义(P0.05)。当上调FOXC1后,SKOV3细胞的增殖活性较2组对照组降低,且差异具有统计学意义(P0.05)。2.2 FOXC1对各组SKOV3细胞侵袭能力的影响情况各组SKOV3细胞种板24h后,在光镜下计数各组细胞穿膜数,下调FOXC1组穿膜数较2组对照组相比明显增多,差异具有统计学意义(P0.05)。上调FOXC1组与2组对照组相比细胞穿膜数明显减少,且差异具有统计学意义(P0.001)。3 FOXC1各组细胞MMP9、MCM2的mRNA和蛋白的表达情况3.1干扰FOXC1后SKOV3细胞中MMP9、MCM2的mRNA及蛋白水平变化情况经qRT-PCR检测,结果显示:下调FOXC1组的SKOV3细胞与2组对照组相比,MMP9、MCM2的mRNA表达量明显增加,差异有统计学意义(P0.05)。应用Western blot检测显示:下调FOXC1组的SKOV3细胞与2组对照组相比,MCM2的蛋白水平表达量增加,差异具有统计学意义(P0.05)。3.2过表达FOXC1后SKOV3细胞中MMP9、MCM2的mRNA及蛋白水平变化情况经qRT-PCR检测,上调FOXC1组的SKOV3细胞较2组对照组相比MMP9、MCM2的mRNA表达量减少,差异均有统计学意义(P0.05)。经Western blot检测,结果显示:上调FOXC1组的SKOV3细胞中MMP9、MCM2的蛋白表达量较2组对照组相比明显降低,差异有统计学意义(P0.05)。4 FOXC1各组细胞p65、p-p65的蛋白表达情况4.1干扰FOXC1后SKOV3细胞中p65、p-p65蛋白水平变化情况经Western blot检测,结果显示,下调FOXC1组的SKOV3细胞中p65的蛋白表达量较2组对照组相比有所增多,但差异无统计学意义(P0.05)。下调FOXC1组中p-p65的蛋白表达量较2组对照组明显增加,差异具有统计学意义(P0.05)。4.2过表达FOXC1后SKOV3细胞中p65、p-p65蛋白水平变化情况经Western blot检测,结果显示:SKOV3细胞中上调FOXC1组p65的蛋白表达量较2组对照组降低,但差异无统计学意义(P0.05)。上调FOXC1组p-p65的蛋白表达量较2组对照组明显降低,差异具有统计学意义(P0.05)。结论分别成功构建了FOXC1干扰及过表达SKOV3细胞稳定株。在上皮性卵巢癌SKOV3细胞中,下调FOXC1能够促进肿瘤细胞的增殖侵袭能力,上调FOX C1能够抑制肿瘤细胞的增殖侵袭能力。FOXC1可能是通过激活NF-κB信号传导通路实现对上皮性卵巢肿瘤细胞生物学功能的调控,在一定程度上参与卵巢癌的发生发展。
[Abstract]:Epithelial ovarian cancer (EOC) is one of the most common malignant tumor of reproductive system in women. At present, the mortality rate of EOC in developed countries is the first in gynecologic tumors. For malignant tumors, tumor cells are most threatened by the invasion of tumor cells in addition to active proliferation. At present, some target experiments and exploration of some genes affecting the biological function of tumor cells have been carried out at home and abroad. Intervention on its targets also promotes the development of tumor therapy and provides more reference for targeted therapy. For EOC, it is clear whether the abnormal expression of some genes can be expressed. The changes in biological behavior of epithelial ovarian cancer cells and further study of its regulatory mechanism are of great significance for the in-depth study of the etiological mechanism of EOC and long-term targeting therapy. The transcription factor FOXC1 (forkhead box C1) is a member of the forkhead transcription factor gene family (FOX family), which combines the binding domain of the DNA binding domain of the forked region of the DNA. In addition to participating in biological processes such as cell or organ differentiation and metabolism, the gene fragment, in addition to the biological processes such as cell or organ differentiation and metabolism, has shown that FOXC1 can also regulate the signal transduction pathways of various tumor cells, such as NF- kappa B, Wnt/ beta -Catenin, and so on. These cell signaling pathways are closely related to cell proliferation, invasion, migration, and apoptosis, thus, FOXC1, FOXC1 The micro chromosome maintenance protein 2 (minichromosomemai n-tenance proteins 2, MCM2) is a new indicator of cell proliferation activity, which is more specific and sensitive when it is used to reflect cell proliferation. Matrix metal egg white enzyme 9 (matrix metallopro teinase, MMP9) is used as a cell. The main protein hydrolase degrading of the external matrix is closely related to the invasion of tumor cells and the degradation of extracellular matrix related to metastasis. Therefore, MCM2, MMP9 changes are often detected at the molecular level when the proliferation and invasion of tumor cells in EOC are at the molecular level. In recent years, it has been reported that FOXC1 is benign in ovarian tumor tissues. The expression rate of epithelial ovarian tumor was 84%. The expression rate in epithelial ovarian cancer was 37.5%. in the previous study group. The expression of FOXC1 mRNA in epithelial ovarian cancer tissue was less than that of borderline ovarian epithelial tumor tissue and benign ovarian epithelial tumor tissue, and the mRNA expression of FOXC1 in the tissues and lymph nodes The deletion of FOXC1 expression in the tissue may be of great significance to the development of epithelial ovarian cancer. However, it is not clear whether the abnormal expression of FOXC1 can cause the biological function of epithelial ovarian cancer cells and how to participate in the development of EOC. In addition, a large number of studies have shown that the NF- kappa B signal transduction pathway in EOC has been shown. The road can be involved in the regulation of MCM2 and MMP9. Therefore, this topic will discuss whether FOXC1 is involved in the malignant biological behavior of epithelial ovarian cancer cells and whether it can be regulated by the NF- kappa B signaling pathway. The purpose of this study is to construct FOXC1 overexpression and interfere with stable cells in the SKOV3 of epithelial ovarian cancer cells by the way of lentivirus infection. After the study, the effects of FOXC1 on the proliferation and invasion of SKOV3 cells were investigated, and whether FOXC1 could be regulated by activating NF- kappa B signaling pathway and analyzing the role of abnormal FOXC1 expression in EOC. Materials and methods 1 research subjects and groups selected human epithelial ovarian cancer cell line SKOV3 cells (Fourth Military Medical doctors) Professor Zhao Ya, Professor Kui Zeng of the Institute of pathogenic biology of the University, used the RPMI-1640 complete culture medium to place cells in the incubator of 37 C and 5%CO2. Experimental groups: experimental group (group FOXC1 Overexpress, FOXC1shRNA group), carrier control group (Overexpress Control group, shRNA Control group) and.2 control group (Control group).2 experiment method in The SKOV3 cells of epithelial ovarian cancer were infected with lentivirus FOXC1 shRNA, FOXC1 lentivirus vector overexpressed plasmids, and the stable cell lines were constructed to verify the level of mRNA and protein respectively. CCK-8 experiment and Transwell experiment were used to observe the proliferation of SKOV3 cells and the changes of invasion ability. MCM2, MMP9 of each group were detected by qRT-PCR method. Western blot method was used to detect the protein expression level of MCM2, MMP9, NF- kappa B p65 and NF- kappa B p-p65 in each group. The statistical analysis of.3 statistical processing was carried out by mRNA software. The experimental data were compared with each other, and the normal distribution was analyzed by single factor analysis of variance and independent sample test. Kruskal-Wallis test and rank sum test were used in the measurement data of partial distribution. Test level alpha =0.05. results 1 stable strain construction and identification of 3 FOXC1 interference sequences by qRT-PCR screening, FOXC1 shRNA1 inhibition effect is the best, select the sequence, through infection and purinomycin screening, Western blot validation, knot The results showed that the expression of FOXC1 protein in the experimental group was significantly lower than that in the vector control group and the blank control group. The difference was statistically significant (P0.05). The FOXC1 interference stable strain was successfully constructed in the SKOV3 cells. The SKOV3 cells were successfully infected with the FOXC1 lentivirus vector overexpression plasmid, and it was screened by purinicamycin and verified by qRT-PCR and Western blot. In the experimental group, the expression level and protein level of FOXC1 in mRNA were significantly higher than those in the 2 groups, and the difference was statistically significant (P0.05). The effect of.2 FOXC1 on the proliferation of SKOV3 cells and the invasiveness of SKOV3 cells were successfully obtained. 2.1 FOXC1 on the proliferation of SKOV3 cells in each group by CCK-8 detection of SKOV3 thin. The results of cell proliferation showed that the cell absorbency of 0h groups was not different. The proliferation activity of SKOV3 cells in the FOXC1 group was higher than that of the 2 groups, especially after 48h, the proliferation activity was significantly higher, and the difference was statistically significant (P0.05). The proliferation activity of SKOV3 cells was lower than that of the control group of the 2 groups after the up regulation of FOXC1, and the difference was found. The effect of statistical significance (P0.05).2.2 FOXC1 on the invasive ability of SKOV3 cells in each group, after 24h of SKOV3 cells, the number of membranes in each group was counted under light microscope, and the number of membrane in the FOXC1 group was significantly increased compared with the control group in the 2 groups, the difference was statistically significant (P0.05). The number of cell transmissions compared with the 2 group was significantly higher than that of the control group. The difference was statistically significant (P0.001).3 FOXC1 cells MMP9, mRNA and protein expression of MCM2 3.1 interfered MMP9 in SKOV3 cells after FOXC1, mRNA and protein levels of MCM2 were detected by qRT-PCR detection. The difference was statistically significant (P0.05). The application of Western blot detection showed that the protein level expression of MCM2 was increased in the SKOV3 cells of the down-regulation group compared with the 2 groups, and the difference was statistically significant (P0.05).3.2 overexpressed FOXC1 in SKOV3 cells. 3 cells were compared with the control group of the 2 group MMP9, and the expression of mRNA in MCM2 decreased, the difference was statistically significant (P0.05). The results showed that the expression of MMP9 in SKOV3 cells of the FOXC1 group was higher than that of the control group of the 2 groups. The difference was statistically significant compared with the control group, and the difference was statistically significant (P0.05). The changes of p65 and p-p65 protein in SKOV3 cells after FOXC1 interference after FOXC1 were detected by Western blot. The results showed that the protein expression of p65 in SKOV3 cells of the down regulated FOXC1 group increased compared with those of the control group, but the difference was not statistically significant (P0.05). The protein expression of p-p65 in the FOXC1 group was significantly higher than that of the control group of 2 groups. The variation of p65 and p-p65 protein levels in SKOV3 cells after FOXC1 was statistically significant (P0.05).4.2 was detected by Western blot. The results showed that the protein expression of p65 in the up regulation of FOXC1 group in SKOV3 cells was lower than that of the control group, but the difference was not statistically significant (P0.05). The amount of protein expression in the up regulation group was compared with the control group of the 2 group. The difference was statistically significant (P0.05). Conclusion FOXC1 interference and overexpression of SKOV3 cell stable strain were successfully constructed. In the SKOV3 cells of epithelial ovarian cancer, the down regulation of FOXC1 could promote the proliferation and invasion of tumor cells, and the up regulation of FOX C1 to inhibit the proliferation and invasion of tumor cells may be by activating NF- kappa B. Signal transduction pathway can regulate the biological function of epithelial ovarian tumor cells and participate in the development of ovarian cancer to some extent.
【学位授予单位】:郑州大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.31
【相似文献】
相关期刊论文 前10条
1 高国兰,牛晓宇,张崇淑,彭芝兰;40岁以下妇女上皮性卵巢癌的临床及病理特点[J];实用癌症杂志;2000年03期
2 管先华,谢瑞梦,赵晓虹,田昌英;上皮性卵巢癌远处转移15例分析[J];四川肿瘤防治;2001年01期
3 王常玉,顾美皎,王世宣,马丁;三种化疗方案治疗晚期上皮性卵巢癌的疗效比较[J];实用妇产科杂志;2002年04期
4 李双弟,万小平,杨兆瑞,胡宏慧,席晓薇,徐先明;血管内皮生长因子及其受体与上皮性卵巢癌发展[J];肿瘤;2003年03期
5 袁令芹;上皮性卵巢癌226例临床病理分析[J];肿瘤防治杂志;2003年08期
6 周晓亮 ,陈轶群;血小板计数与晚期上皮性卵巢癌患者二探结果及疾病进展的关系[J];国外医学.妇产科学分册;2004年06期
7 赵玲军;术中即时化疗在上皮性卵巢癌治疗中的应用[J];中国基层医药;2005年10期
8 Hopkins L.;Fung Kee Fung M.;王颖;;上皮性卵巢癌进展期辅助和补救化疗过程中患者生活质量评估[J];世界核心医学期刊文摘(妇产科学分册);2005年11期
9 王鑫;吕杰强;朱雪琼;;胰岛素样生长因子系统在上皮性卵巢癌中的研究进展[J];国外医学.妇产科学分册;2006年04期
10 李海玲;任慕兰;钱惠勤;;上皮性卵巢癌血管内皮生长因子表达及微血管密度[J];江苏医药;2007年01期
相关会议论文 前10条
1 程蓓;郭轶男;吕卫国;万小云;陈亚侠;谢幸;;上皮性卵巢癌患者保留生育功能13例分析[A];第四届长三角妇产科学术论坛暨浙江省2009年妇产科学术年会论文汇编[C];2009年
2 许红;;Ⅲ期上皮性卵巢癌的治疗与预后分析[A];中国抗癌协会妇科肿瘤专业委员会第六次全国学术会议论文汇编[C];2001年
3 周慧梅;黄惠芳;潘凌亚;沈铿;吴鸣;杨佳欣;;血清CA125值的变化对判断上皮性卵巢癌预后的临床价值[A];中华医学会第九次全国妇科肿瘤学术会议论文汇编[C];2006年
4 叶海燕;陈建国;徐嘉文;陈志红;;has-miRNA let-7a在上皮性卵巢癌中的表达及其临床意义[A];中华医学会第十次全国妇产科学术会议妇科肿瘤会场(妇科肿瘤学组、妇科病理学组)论文汇编[C];2012年
5 谢敏;李艺;崔恒;;复发性上皮性卵巢癌的手术治疗[A];中华医学会第十次全国妇产科学术会议妇科肿瘤会场(妇科肿瘤学组、妇科病理学组)论文汇编[C];2012年
6 许红;王中弥;左馨;;Ⅲ期上皮性卵巢癌58例临床分析[A];中国抗癌协会妇科肿瘤专业委员会第七次全国学术会议论文汇编[C];2003年
7 郄明蓉;杨小芸;张崇淑;;28例Ⅳ期及复发上皮性卵巢癌的治疗选择与预后分析[A];中国抗癌协会妇科肿瘤专业委员会第七次全国学术会议论文汇编[C];2003年
8 郄明蓉;郑艾;杨小芸;张崇淑;;28例Ⅳ期及复发上皮性卵巢癌的治疗选择与预后分析[A];第八次全国妇产科学学术会议论文汇编[C];2004年
9 郄明蓉;张崇淑;郑艾;杨小芸;;28例Ⅳ期及复发上皮性卵巢癌的治疗选择与预后分析[A];第八次全国妇产科学学术会议论文汇编[C];2004年
10 彭素蓉;王金华;陈小祥;;上皮性卵巢癌系统性腹膜后淋巴结切除术及临床意义——附102例报告[A];江苏省抗癌协会妇科肿瘤专业委员会第四次肿瘤学术研讨会暨无锡市妇产科年会论文汇编[C];2005年
相关博士学位论文 前10条
1 王宇;FoxM1剪接异构体在上皮性卵巢癌中的表达及相关功能研究[D];第四军医大学;2013年
2 金佟;CA125/T ELISA法用于CA125升高的良恶性鉴别及其临床应用[D];复旦大学;2014年
3 严春晓;水通道蛋白亚型AQP5及AQP9在上皮性卵巢癌细胞增殖与迁移中的功能研究[D];浙江大学;2015年
4 黄宇婷;基于定量多色荧光原位杂交技术的卵巢癌多基因拷贝数异常的研究[D];天津医科大学;2015年
5 冷若冰;Rac1在上皮性卵巢癌上皮间质转化中的作用及机制的初步研究[D];重庆医科大学;2015年
6 梁军;肿瘤干细胞样细胞在上皮性卵巢癌血管生成拟态中作用的研究[D];河北医科大学;2016年
7 胡建国;MARCH7促进上皮性卵巢癌恶性进展及机制的研究[D];重庆医科大学;2016年
8 陆萌;FKBP14对上皮性卵巢癌细胞增殖和迁移能力的影响[D];南京医科大学;2016年
9 牛海英;PPA1通过促进上皮—间质转化影响上皮性卵巢癌的转移[D];天津医科大学;2016年
10 郭立丽;靶向谷氨酰胺代谢逆转上皮性卵巢癌铂类及m-TOR抑制剂耐药的机制研究[D];华中科技大学;2016年
相关硕士学位论文 前10条
1 杨一鸣;血小板增多症在上皮性卵巢癌中的诊断意义及预后评估[D];大连医科大学;2013年
2 邱章灿;Ⅲc期上皮性卵巢癌预后危险因素与无进展生存期关系探讨[D];广西医科大学;2015年
3 秦凯云;上皮性卵巢癌患者血浆化疗耐药相关蛋白质分析及临床意义[D];河北医科大学;2015年
4 董杰;上皮性卵巢癌中TGF-β1的表达与耐药相关基因的关系[D];河北医科大学;2015年
5 齐新颖;LRP、GST-π表达与上皮性卵巢癌铂类化疗耐药及预后的关系[D];河北医科大学;2015年
6 田美玲;ERCC1基因多态性及蛋白表达与上皮性卵巢癌铂类化疗敏感性及预后关系的研究[D];河北医科大学;2015年
7 贾亚静;子宫内膜癌、上皮性卵巢癌、早期宫颈癌预后因素分析[D];河北医科大学;2015年
8 杨晗;77例上皮性卵巢癌预后相关因素分析[D];河北医科大学;2015年
9 张根豪;阿司匹林对人上皮性卵巢癌SKOV3细胞SOX7表达和Wnt/β-catenin信号通路的影响[D];郑州大学;2015年
10 肖喜云;HER2蛋白在上皮性卵巢癌中的表达及曲妥珠单抗对卵巢癌SKOV3细胞的影响[D];河北医科大学;2015年
,本文编号:1913247
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/1913247.html